✦ LIBER ✦

A phase II parallel group study with letrozole plus goserelin in premenopausal, and letrozole in postmenopausal metastatic breast cancer patients as first line hormone therapy

✍ Scribed by J. Ro; K.S. Lee; H. Han; E. Lee; H.S. Kang; S.W. Kim; Y. Kwon; B. Nam

Book ID: 119598230
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 60 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70738-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5048 A Q-TWiST analysis of lapatinib plu

5048 A Q-TWiST analysis of lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive (HR+) metastatic breast cancer (MBC)

✍ B. Sherrill; M. Amonkar; B. Sherif; J. Maltzman; L. O'Rourke; S. Johnston 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

Phase II study of gefitinib in combinati

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

✍ Ciardiello, F; Troiani, T; Caputo, F; De Laurentiis, M; Tortora, G; Palmieri, G; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

A multi-center phase II study of docetax

A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

✍ Jin Young Kim; Young Rok Do; Keon Uk Park; Min Kyung Kim; Kyung Hee Lee; Sung Hw 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 200 KB

First line therapy with paclitaxel (Taxo

First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

PP-7-5 phase II study of paclitaxel (P)

PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)

✍ Ch. Thomssen; H.-J. Lück; A. du Bois; B. Lisboa; M. Untch; G. Köhler; D. Hecker; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB